GO:0000245 spliceosomal complex assembly: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000245 (spliceosomal complex assembly) describes the stepwise aggregation, arrangement and bonding of snRNPs and protein factors into a functional spliceosome that catalyzes nuclear pre-mRNA splicing [1,6].
• Assembly proceeds through the E, A, B and Bact complexes, with the cross-exon to cross-intron switch being a key regulatory transition.
• The spliceosome is a dynamic ribonucleoprotein machine that undergoes extensive compositional and conformational changes during each splicing cycle [1,3,6].
• Dysregulation of spliceosomal assembly is linked to cancer, neurodegeneration and developmental disorders, often through mutations in core components such as SF3B1 [5,7].
• CDK11-mediated phosphorylation of SF3B1 regulates spliceosome assembly and splicing fidelity.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential for dissecting the causal roles of spliceosomal genes in disease [5,7].
Description
Spliceosomal complex assembly (GO:0000245) is the biological process by which small nuclear ribonucleoproteins (snRNPs) and numerous auxiliary proteins come together to form the spliceosome, the macromolecular machine responsible for removing introns from pre-mRNA [1,6]. This assembly is not a simple one-step event but a highly ordered, ATP-dependent cascade that ensures accurate recognition of splice sites and catalytic activation [1,3]. Understanding this process is fundamental to molecular biology because alternative splicing, which is driven by spliceosome dynamics, expands proteome diversity and regulates gene expression in development and disease. Defects in spliceosomal assembly are increasingly recognized as drivers of cancer and other disorders, making it a prime target for therapeutic intervention and functional genomics [5,7].
spliceosomal complex assembly At A Glance
| GO ID | GO:0000245 |
|---|---|
| GO term | spliceosomal complex assembly |
| Ontology | biological_process |
| Synonym | spliceosome assembly |
| Definition | The aggregation, arrangement and bonding together of a spliceosomal complex, a ribonucleoprotein apparatus that catalyzes nuclear mRNA splicing via transesterification reactions. |
| Major function | Assembly of the spliceosome for pre-mRNA splicing |
| Related processes | mRNA splicing, spliceosome disassembly, alternative splicing |
| Key complexes | E, A, B, Bact, C, and post-splicing complexes |
What Is GO:0000245?
According to the Gene Ontology, GO:0000245 (spliceosomal complex assembly) is defined as the aggregation, arrangement and bonding together of a spliceosomal complex, a ribonucleoprotein apparatus that catalyzes nuclear mRNA splicing via transesterification reactions. In simpler terms, it is the process of building the spliceosome from its component parts, including snRNPs and associated proteins, into a functional unit capable of splicing pre-mRNA [1,6].
Why Is spliceosomal complex assembly Important in Cell Biology?
Spliceosomal complex assembly is essential for the fidelity of pre-mRNA splicing, a process that affects nearly all human genes and is critical for cellular homeostasis [1,2]. Errors in assembly can lead to aberrant splicing, which is associated with a wide range of diseases including cancer, neurodegeneration, and developmental disorders [5,7]. Moreover, the assembly process is a hub for regulatory inputs, such as phosphorylation by CDK11, that modulate splicing outcomes in response to cellular signals. Therefore, studying spliceosomal assembly provides insights into basic gene regulation and offers potential therapeutic targets for splicing-related diseases.
• Ensures accurate removal of introns and joining of exons, fundamental to gene expression [1,6].
• Dysregulation is linked to hematological malignancies and solid tumors through mutations in SF3B1 and other spliceosome components [5,7].
• Alternative splicing, which depends on spliceosome assembly, generates protein diversity in development and tissue-specific functions.
• Spliceosomal assembly is a target of natural regulatory mechanisms, including phosphorylation by CDK11.
• Defects in assembly can cause neurodegeneration, as seen in spinal muscular atrophy and other RNA-processing disorders.
• Understanding assembly mechanisms aids in the design of splicing-modulating therapeutics.
• Assembly intermediates are potential biomarkers for cancer diagnosis and prognosis.
• CRISPR screens targeting spliceosomal genes can uncover vulnerabilities in cancer cells.
What Happens During spliceosomal complex assembly?
Early recognition and E complex formation
In simple terms: The cell first identifies the intron and brings together the U1 snRNP and other factors to form the earliest spliceosomal complex.
Spliceosomal assembly begins with the recognition of the 5' splice site by U1 snRNP and the branch point by SF1/BBP, leading to the formation of the E (commitment) complex [1,6]. This step is ATP-independent and involves base-pairing interactions between U1 snRNA and the pre-mRNA. The E complex is then converted to the A complex upon ATP-dependent addition of U2 snRNP, which base-pairs with the branch point sequence [1,6].
A complex and pre-spliceosome formation
In simple terms: The U2 snRNP joins, creating a pre-spliceosome that commits the pre-mRNA to splicing.
The A complex, also known as the pre-spliceosome, contains U1 and U2 snRNPs and is stabilized by ATP hydrolysis. The U2 snRNP protein SF3B1 interacts with the branch point, and its phosphorylation by CDK11 regulates this step. The A complex is a key checkpoint for splice site selection and is targeted by regulatory factors.
Tri-snRNP recruitment and B complex formation
In simple terms: The U4/U6.U5 tri-snRNP joins the pre-spliceosome to form the mature spliceosome.
The B complex forms when the U4/U6.U5 tri-snRNP associates with the A complex, bringing in U5 snRNP and associated proteins [1,6]. This step involves extensive RNA-RNA rearrangements and is ATP-dependent. The B complex then undergoes activation to the Bact complex, where U1 and U4 are released, and the catalytic core is formed [1,6].
Cross-exon to cross-intron switch
In simple terms: The spliceosome transitions from recognizing exons to recognizing introns, a critical step for splicing fidelity.
Recent structural studies have revealed that the spliceosome undergoes a cross-exon to cross-intron switch during assembly, which is essential for correct splice site pairing. This switch involves major conformational changes and is regulated by specific proteins and RNA interactions. Defects in this transition can lead to aberrant splicing and disease.
Catalytic activation and disassembly
In simple terms: The spliceosome becomes catalytically active and then falls apart after splicing.
The Bact complex is converted to the C complex after the first transesterification reaction, and then to the post-splicing complex after the second reaction [1,6]. Disassembly of the spliceosome is an active process that requires ATP and specific factors, as recently elucidated. This step is crucial for recycling of spliceosomal components and for termination of the splicing cycle.
Key Genes Involved in GO:0000245 spliceosomal complex assembly
The following genes encode core components and regulators of spliceosomal complex assembly, with their roles and research relevance summarized.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SF3B1 | U2 snRNP component, branch point recognition | Frequently mutated in cancer; target of CDK11 phosphorylation |
| U2AF1 | Splicing factor, 3' splice site recognition | Mutated in myelodysplastic syndromes and cancers |
| SRSF2 | Serine/arginine-rich splicing factor, exon enhancer binding | Mutated in leukemia and other cancers |
| SNRPB | Core snRNP protein | Essential for snRNP assembly; linked to developmental disorders |
| PRPF8 | U5 snRNP protein, catalytic core component | Mutations cause retinitis pigmentosa |
| DDX46 | RNA helicase, involved in spliceosome assembly | Regulates splicing and is implicated in cancer |
| CDK11 | Kinase that phosphorylates SF3B1 | Regulates spliceosome assembly and splicing |
| EFTUD2 | U5 snRNP component, GTPase | Mutations cause mandibulofacial dysostosis |
| SNRPD3 | Core snRNP protein | Required for snRNP biogenesis |
| LSM2 | U6 snRNP component | Involved in spliceosome activation |
| PRPF19 | Pre-mRNA processing factor | Part of the Prp19 complex, essential for activation |
| AQR | Intron-binding protein, spliceosome disassembly | Required for spliceosome recycling |
| DHX15 | RNA helicase, disassembly factor | Mediates spliceosome disassembly |
| SNRNP200 | U5 snRNP helicase | Mutations linked to retinitis pigmentosa |
| RBM39 | Splicing factor, interacts with SF3B1 | Target of anticancer drugs |
| U2AF2 | U2AF65, 3' splice site recognition | Mutated in cancer |
| SF3A1 | U2 snRNP component | Essential for A complex formation |
| SART1 | U4/U6.U5 tri-snRNP component | Involved in tri-snRNP assembly |
How Is spliceosomal complex assembly Regulated?
Spliceosomal complex assembly is regulated at multiple levels, including post-translational modifications of core components. For example, CDK11 phosphorylates SF3B1 to regulate spliceosome assembly and splicing fidelity. Additionally, the assembly process is coupled to transcription and is influenced by the phosphorylation state of splicing factors. The cross-exon to cross-intron switch is a regulatory checkpoint that can be modulated by specific proteins. Disassembly is also actively regulated by factors such as DHX15 and AQR.
spliceosomal complex assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SF3B1 | Myelodysplastic syndromes, leukemia | Knock-in of mutant SF3B1 in hematopoietic cells |
| U2AF1 | Myelodysplastic syndromes, lung cancer | Knockout and point mutation in cell lines |
| PRPF8 | Retinitis pigmentosa | Knock-in mouse models |
| EFTUD2 | Mandibulofacial dysostosis | Knockout zebrafish or mouse |
| CDK11 | Cancer, splicing regulation | Knockout and overexpression in cancer cell lines |
Spliceosomal assembly in cancer
Mutations in spliceosomal genes such as SF3B1, U2AF1, and SRSF2 are common in myelodysplastic syndromes, leukemia, and solid tumors. These mutations often lead to aberrant splicing and altered assembly dynamics, contributing to oncogenesis. CDK11-mediated phosphorylation of SF3B1 is a potential therapeutic target in cancers with spliceosome mutations.
Neurodegeneration and spliceosomal dysfunction
Defects in spliceosomal assembly can cause neurodegeneration, as seen in retinitis pigmentosa linked to PRPF8 and SNRNP200 mutations. Impaired assembly may lead to accumulation of aberrant transcripts and neuronal death.
Developmental disorders
Mutations in core spliceosomal components such as EFTUD2 cause mandibulofacial dysostosis, highlighting the importance of assembly in development. These disorders often result from haploinsufficiency of spliceosomal genes.
From spliceosomal complex assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of SF3B1 hotspot mutations on spliceosome assembly? | Point mutation knock-in cell lines |
| How does CDK11 loss affect splicing and assembly? | CRISPR knockout of CDK11 |
| Can overexpression of wild-type SF3B1 rescue splicing defects? | Overexpression cell models |
| What is the interactome of spliceosomal assembly intermediates? | Tagged knock-in of core components |
| Which genes are essential for spliceosome assembly? | Genome-wide CRISPR knockout library screening |
| How does a disease-associated mutation alter assembly dynamics? | Knock-in of patient-derived mutations |
How to Study the spliceosomal complex assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Splicing patterns and gene expression | Assessing impact of spliceosomal mutations |
| RT-PCR | Specific splicing events | Validating alternative splicing changes |
| AP-MS | Protein interactions | Identifying spliceosome components |
| Cryo-EM | 3D structures of complexes | Visualizing assembly intermediates |
| CRISPR knockout screens | Gene essentiality and fitness | Identifying assembly factors |
| Phosphoproteomics | Phosphorylation status | Studying CDK11-mediated regulation |
| Single-molecule FRET | Conformational dynamics | Real-time assembly studies |
RNA-based methods
RNA-seq and RT-PCR are used to assess splicing changes upon perturbation of spliceosomal genes. These methods can detect intron retention, exon skipping, and alternative splice site usage, providing functional readouts of assembly defects.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry (AP-MS) identifies protein-protein interactions within assembling spliceosomes. This approach has been used to define the composition of E, A, B, and C complexes [1,6].
Structural biology
Cryo-electron microscopy (cryo-EM) has provided near-atomic resolution structures of spliceosomal complexes at various assembly stages. These studies reveal conformational changes and RNA rearrangements during assembly.
Functional genomics
CRISPR-based knockout screens and RNAi have been used to identify genes required for spliceosome assembly and cell viability. These screens can uncover synthetic lethal interactions with spliceosomal mutations.
How CRISPR Can Be Used to Study GO:0000245 spliceosomal complex assembly
Knockout
CRISPR knockout of core spliceosomal genes such as SF3B1 or CDK11 can reveal their essentiality and impact on assembly. However, complete knockouts of essential genes may be lethal, requiring inducible systems.
Point Mutation
Knock-in of specific point mutations, such as SF3B1 K700E, allows study of disease-associated variants in an isogenic background. These models are valuable for understanding how mutations alter assembly and splicing.
Knock-in
Tagged knock-in of spliceosomal proteins (e.g., GFP or FLAG) enables live-cell imaging and affinity purification of assembly intermediates. This approach helps track assembly dynamics in real time.
Overexpression
Overexpression of wild-type or mutant spliceosomal genes can model gain-of-function effects and rescue experiments. This is useful for studying regulatory mechanisms and dominant-negative effects.
How EDITGENE Supports spliceosomal complex assembly Research
Researchers studying spliceosomal complex assembly-related genes often need to determine whether a candidate gene is causally involved in assembly, splicing, or disease. EDITGENE provides a comprehensive suite of CRISPR services to create precise cellular models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for spliceosomal complex assembly research.
Frequently Asked Questions About spliceosomal complex assembly
What is spliceosomal complex assembly?
Spliceosomal complex assembly (GO:0000245) is the process of building the spliceosome, a ribonucleoprotein machine that catalyzes pre-mRNA splicing [1,6].
What genes are involved in spliceosomal complex assembly?
Key genes include SF3B1, U2AF1, SRSF2, PRPF8, CDK11, and many snRNP components [1,5,7].
What are the steps of spliceosome assembly?
The main steps are E complex formation, A complex (pre-spliceosome), B complex, Bact, C, and post-splicing complex, with a cross-exon to cross-intron switch [1,6,8].
How is spliceosomal assembly regulated?
It is regulated by phosphorylation events, such as CDK11-mediated phosphorylation of SF3B1, and by conformational switches [7,8].
What diseases are linked to spliceosome assembly defects?
Cancer, retinitis pigmentosa, and developmental disorders like mandibulofacial dysostosis [3,5].
What methods are used to study spliceosomal assembly?
RNA-seq, AP-MS, cryo-EM, and CRISPR screens are commonly used [1,5,8].
What is the role of SF3B1 in spliceosome assembly?
SF3B1 is a U2 snRNP component that recognizes the branch point and is frequently mutated in cancer.
How does CDK11 regulate splicing?
CDK11 phosphorylates SF3B1 to control spliceosome assembly and splicing fidelity.
What is the cross-exon to cross-intron switch?
It is a structural transition during spliceosome assembly that ensures correct splice site pairing.
How can CRISPR help study spliceosome assembly?
CRISPR knockout, knock-in, and point mutation models allow functional dissection of spliceosomal genes in disease contexts [5,7].
Conclusion
Spliceosomal complex assembly (GO:0000245) is a highly orchestrated process essential for pre-mRNA splicing and gene expression. Its dysregulation is implicated in cancer, neurodegeneration, and developmental disorders, making it a critical area of research. Advances in structural biology and CRISPR-based models continue to unravel the molecular details of assembly, offering new opportunities for therapeutic intervention.
References
- 1. Will CL et al.. 2011. Spliceosome structure and function.. Cold Spring Harb Perspect Biol 3(7) PMID: 21441581
- 2. Lee Y et al.. 2015. Mechanisms and Regulation of Alternative Pre-mRNA Splicing.. Annu Rev Biochem 84:291-323 PMID: 25784052
- 3. Matera AG et al.. 2014. A day in the life of the spliceosome.. Nat Rev Mol Cell Biol 15(2):108-21 PMID: 24452469
- 4. Vorländer MK et al.. 2024. Mechanism for the initiation of spliceosome disassembly.. Nature 632(8024):443-450 PMID: 38925148
- 5. Inoue D et al.. 2019. Spliceosomal disruption of the non-canonical BAF complex in cancer.. Nature 574(7778):432-436 PMID: 31597964
- 6. Wahl MC et al.. 2009. The spliceosome: design principles of a dynamic RNP machine.. Cell 136(4):701-18 PMID: 19239890
- 7. Hluchý M et al.. 2022. CDK11 regulates pre-mRNA splicing by phosphorylation of SF3B1.. Nature 609(7928):829-834 PMID: 36104565
- 8. Zhang Z et al.. 2024. Structural insights into the cross-exon to cross-intron spliceosome switch.. Nature 630(8018):1012-1019 PMID: 38778104
